CN1244335C - 抗流感药物 - Google Patents
抗流感药物 Download PDFInfo
- Publication number
- CN1244335C CN1244335C CN 03126177 CN03126177A CN1244335C CN 1244335 C CN1244335 C CN 1244335C CN 03126177 CN03126177 CN 03126177 CN 03126177 A CN03126177 A CN 03126177A CN 1244335 C CN1244335 C CN 1244335C
- Authority
- CN
- China
- Prior art keywords
- radix
- root
- influenza
- rhizoma
- cold
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract 3
- 241000756943 Codonopsis Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- PGZUMBJQJWIWGJ-ONAKXNSWSA-N oseltamivir phosphate Chemical compound OP(O)(O)=O.CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 PGZUMBJQJWIWGJ-ONAKXNSWSA-N 0.000 claims description 7
- 229940061367 tamiflu Drugs 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 206010022000 influenza Diseases 0.000 abstract description 16
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 241000229179 Ledebouriella Species 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 241000219780 Pueraria Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 229940023019 aconite Drugs 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 230000000312 effect on influenza Effects 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 238000010438 heat treatment Methods 0.000 description 12
- 238000009826 distribution Methods 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 208000008454 Hyperhidrosis Diseases 0.000 description 6
- 206010039101 Rhinorrhoea Diseases 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 208000010753 nasal discharge Diseases 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010063659 Aversion Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 208000013219 diaphoresis Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 201000009240 nasopharyngitis Diseases 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229960005489 paracetamol Drugs 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002650 habitual effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- 206010003757 Atypical pneumonia Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229960000741 erythromycin ethylsuccinate Drugs 0.000 description 1
- NSYZCCDSJNWWJL-YXOIYICCSA-N erythromycin ethylsuccinate Chemical compound O1[C@H](C)C[C@H](N(C)C)[C@@H](OC(=O)CCC(=O)OCC)[C@@H]1O[C@H]1[C@@](O)(C)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(OC)C2)[C@@H]1C NSYZCCDSJNWWJL-YXOIYICCSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000009792 yinqiao Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种抗流感药物,它是由下列重量配比的原料制成的药剂:桂枝3-15g,生姜3-10g,防风3-15g,附子3-7g,葛根9-15g,黄莲4.5-35g,党参3-30g,黄芪10-30g,生地10-30g,白术5-15g,竹叶5-12g。本发明对流感有显著疗效,数年来,共治疗流感三百例,其有效率达到99%,治愈率为95%,无毒副作用。
Description
技术领域
本发明涉及一种治疗流行性感冒的中药。
背景技术
感冒有流行性感冒和普通感冒两类,前者主要由流感病毒引起,后者则主要由鼻病毒引起,两者发病率均很高,感冒的危害除了造成上呼吸道粘膜水肿、充血、浅表性溃疡及其它炎症外,还可并发引起一系列病症如心肌炎、肺炎和哮喘等病,也是导致老人、儿童患者死亡的主要原因之一。目前治疗感冒的药物大致有三类,一为纯西药制成的感冒药,主要是针对上呼吸道感染及全身发热症状而使用的抗感染、抗过敏和发汗退热的成份单独或组合制成的药物。二为中药和西药的组合物,以解表类中药和抗过敏类西药配合制成的复方药物。三为纯中药制剂。以上三类药物针对不同类型的感冒均有一定的治疗效果,但含西药成份的药物对人体的副作用相对大一些,而纯中药制剂的疗效又不能令人满意。
发明内容
本发明的目的是提供一种疗效显著的纯中药制剂。
本发明的技术方案是:一种抗流感药物,它是由下列重量配比的原料制成的药剂:桂枝3-15g,生姜3-10g,防风3-15g,附子3-7g,葛根9-15g,黄莲4.5-35g,党参3-30g,黄芪10-30g,生地10-30g,白术5-15g,竹叶6-12g。
上述各中药的用量是指它们之间的重量比利关系,在实际运用当中可以按照重量比利关系成倍的扩打或生产,都属于本发明的范围之内。
上述配方的最佳用量为:
桂枝8g,生姜6g,防风8g,附子5g,葛根11g,黄莲16g,党参16g,黄芪23g,生地20g,白术10g,竹叶9g。
药剂是散剂、口服液或块剂。
本发明所用组份的药理说明:
1、桂枝:性味归经:辛、甘、温、归心、肺、膀胱经。功效:发汗解表温经通阳。应用:用于恶寒、发热、头痛等外风寒表证。
2、生姜:性味归经:辛、微温、归肺、脾经。功效:发汗解表,温中止呕,温肺止咳。应用:恶寒、发热、头痛、鼻塞等外感风寒表证。
3、防风:性味归经:辛、甘、微温、归膀胱、肝、脾经。功效:祛风解表,胜湿,止痛解痉,解附子毒。应用:用于恶寒、发热、头痛、身痛等外风寒表证。
4、附子:性味归经:辛、热、有毒、归心、肾、脾经畏防风。功效:回阳救逆,补火助阳,散寒止痛。应用:用于冷汗自出,四肢厥逆,脉微欲绝之亡阳症。
5、葛根:性味归经:辛、甘、凉、入脾、胃经。功效:发表解肌,升阳透疹,解热生津。应用:用于发热、头痛、无汗、项背强痛、恶风等风寒表证。
6、黄莲:性味归经:苦、寒、归心、胃、肝、大肠经。功效:清热燥湿、泻火解毒。应用:用于呕吐、泻痢等肠胃湿热所致之证。
7、党参:性味归经:甘、平、归脾、肺经。功效:补中益气、生津养血。应用:用于食少便溏,四肢倦怠之中气不足等。
8、黄芪:性味归经:甘、微温、归脾、肺经。功效:补气升阳、益卫固表、托毒生肌、利水消肿。应用:病后气虚体弱,与人参同用,用于气虚阳衰,畏寒多汗,与附子配伍。
9、生地:性味归经:甘、寒、归心、肝、肾经。功效:清热凉血,养阴生津。应用:用于身热,舌绛口干等湿病热入营血证。
10、白术:性味归经:苦、甘、温、归脾、胃经。功效:补气健脾,燥湿利水,止汗安胎。应用:用于脾气虚弱,运化失常所致,食少腹胀,大便溏泻,倦怠无力之证。
11、竹叶:性味归经:甘、淡、寒、无毒、入心、肺、胆、胃经。功效:清热除烦,生津利尿。应用:主治热病烦渴,小儿惊痫,咳逆吐衄,面赤,小便短赤,口糜舌疮。
经日:正气存内,邪不可干,邪之所凑,其气必虚,祖国医学认为,外邪干于人体,必是正气不足的标志,该方不拘泥于传统的组方原则,一反单纯的清热解毒,清热凉血,以独特的组方,温凉并用,寒热相伍,达到益气扶正,疏风祛邪,扶正而不滋邪,祛邪而不伤正,从而具有独特的治疗效果。
数年来,共治疗流感三百例,其有效率达到99%,治愈率为95%,无毒副作用,简举十例如下:
病例一:何某,男性,41岁,机关干部。2001年11月以发热,咽痛,咳嗽,流涕,全身酸楚为主诉,以感冒住院一周,中西医治疗无效,始服该方,一剂中的,二剂痊愈。
病例二:马某,男性,45岁,医务工作者。2002年2月患感冒,全身酸痛,发热,咳嗽,喷嚏眼泪不止,服用抗感冒药无效,服该方二剂告愈。
病例三:张某,男性,43岁,机关干部。2000年春,发热,咳嗽,乏力,流涕,住院以感冒,输液青霉素等,五天后诸证如故,服用本方二剂,诸证皆愈。
病例四:夏某,男性,干部。因习惯性感冒数年,皆以发热,咳嗽,流涕,全身不适,每次必数周难愈,服用本方三剂后,诸证痊愈,且数年不再感冒,说明该方确有增加机体免疫力之功效。
病例五:蔡某,男性,40岁。2002年患感冒,口服伤风感冒胶囊等无效,服本方二剂症状全消。
病例六:李某,女性,40岁,医院护士,患感冒于2002年3月住院输液一周后仍全身困痛,咳嗽,发热,再服银翘片,感冒通等仍不愈,服用本方二剂后诸证全消。
病例七:尚某,女性,35岁,机关干部。因习惯性感冒三年,2001年6月以发热,咳嗽,在县医院输液二十天诸证如故,服用本方二剂后症状缓解,三剂后痊愈。
病例八:何某,女性,32岁,机关干部。2002年12月患感冒,发热,流涕,流泪,咳嗽,全身酸痛,用青霉素输液无效,改用菌必治再用三天后,症状不能缓解,用本方三剂后痊愈。
病例九:狄某,女性,69岁,农民。2003年元月患感冒,咳嗽,流涕,流泪,全身酸痛,乏力,服康必得,草药十多付等,诸证如旧,服用本方三剂痊愈。
病例十:安某,女性,35岁,市民。2000年11月,全家三人共患流感,皆以发热,咳嗽,流涕,身痛为主证,服白加黑,康必得,利君沙等数天不愈,开始服用本方,二剂后,全家三人皆告愈。
综上所述本方持有人认为:疾病的发生,都是在一定条件下正邪斗争的结果,正气旺盛,气血充盈,卫外固密,病邪难于侵入,疾病无从发生,强调正气在发病中的主导地位,但并不排除邪气对疾病发生的重要作用。在一定的情况下,甚至可能起主导作用,有如《温疫论》所描述的“此气之来,无论老少强弱,触之者即病。”又如本次北京市发生的非典型肺炎流行,也说明了多种传染病的发生与流行,邪气是重要的条件而起着主导作用。疾病发生后,体内正气和邪气这两种力量不是固定不变的,而是正邪双方在其斗争的过程中,发生着力量对比上的消长盛衰变化,本方有着扶正祛邪,增强机体免疫力之功效,是治疗流感的奇效之真谛所在。
本发明在河南省中医药研究院进行了毒性试验,结果如下:
实验目的:观察抗流感药物(流感增免灵口服液)以最大浓度和最大可灌胃容量给予小鼠后,所产生的毒性反应和死亡情况。
实验材料:一、受试药物:流感增免灵口服液,2.5g生药/mI,临床用量:每日口服三次,每次20mL,实验时浓缩至4g生药/mL。二、实验动物:昆明种小鼠20只,雌雄各半,体重18.8±0.8g,由河南省实验动物中心提供,合格证:医动字第410115号。
实验方法:实验用昆明种小鼠20只,雌雄各半,体重18.8±0.8g,禁食12h后,以最大浓度(4g生药/mL)及最大可灌胃容积(0.4mL/10g),一日内灌胃三次,每次间隔为6h,给药后常规饲养,连续观察7天。
实验结果:给药后,小鼠活动正常,其毛发、精神状态、饮食及体重变化等均未见异常,七日内无死亡。因给药剂量所限,未测出LD50.故测得流感增免灵口服液的小鼠最大给药量为480g生药/kg体重,相当于临床用药量的192倍。
具体实施方式
实施例1:
按下述配方将原料药配好:桂枝8g,生姜6g,防风8g,附子5g,葛根11g,黄莲16g,党参16g,黄芪23g,生地20g,白术10g,竹叶9g。
实施例2:
按下述配方将原料药配好:桂枝3g,生姜3g,防风3g,附子3g,葛根9g,黄莲4.5g,党参3g,黄芪10g,生地10g,白术5g,竹叶5g。
实施例3:
按下述配方将原料药配好:桂枝15g,生姜10g,防风15g,附子7g,葛根15g,黄莲435g,党参30g,黄芪30g,生地30g,白术15g,竹叶12g。
本药可采用现有通用的方法制备成散剂、口服液或块剂。
Claims (4)
1、一种抗流感药物,其特征是:它是由下列重量配比的原料制成的药剂:桂枝3-15g,生姜3-10g,防风3-15g,附子3-7g,葛根9-15g,黄莲4.5-35g,党参3-30g,黄芪10-30g,生地10-30g,白术5-15g,竹叶5-12g。
2、根据权利要求1所述的抗流感药物,其特征是:其中各原料的重量配比是:桂枝6-12g,生姜5-8g,防风5-10g,附子4-6g,葛根10-13g,黄莲10-25g,党参8-20g,黄芪18-26g,生地16-26g,白术8-12g,竹叶6-10g。
3、根据权利要求1所述的抗流感药物,其特征是:其中各原料的重量配比是:桂枝8g,生姜6g,防风8g,附子5g,葛根11g,黄莲16g,党参16g,黄芪23g,生地20g,白术10g,竹叶9g。
4、根据权利要求1所述的抗流感药物,其特征是:所说的药剂是散剂、口服液或块剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03126177 CN1244335C (zh) | 2003-05-21 | 2003-05-21 | 抗流感药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03126177 CN1244335C (zh) | 2003-05-21 | 2003-05-21 | 抗流感药物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1548123A CN1548123A (zh) | 2004-11-24 |
| CN1244335C true CN1244335C (zh) | 2006-03-08 |
Family
ID=34321889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03126177 Expired - Fee Related CN1244335C (zh) | 2003-05-21 | 2003-05-21 | 抗流感药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1244335C (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101365466A (zh) * | 2005-11-16 | 2009-02-11 | 纳特比奥控股有限公司 | 姜属植物提取物 |
| CN101366510B (zh) * | 2008-09-03 | 2012-04-25 | 李富祥 | 一种具有预防感冒的泡制饮品 |
| CN113521232B (zh) * | 2020-04-21 | 2024-07-02 | 天士力医药集团股份有限公司 | 一种含有白术的中药组合物 |
-
2003
- 2003-05-21 CN CN 03126177 patent/CN1244335C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1548123A (zh) | 2004-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100998843A (zh) | 一种治疗胆囊炎的药物组合物 | |
| CN102058767B (zh) | 治疗老年慢性支气管炎的中药及该中药丸剂的制备方法 | |
| CN103520680A (zh) | 治疗急性心衰的中药 | |
| CN103182019A (zh) | 治疗复发性口腔溃疡的中药组合物 | |
| CN102579610B (zh) | 一种治疗脑出血的中药组合物及其制备方法 | |
| CN104147572A (zh) | 感冒发热疏风散热制剂及制备方法 | |
| CN1244335C (zh) | 抗流感药物 | |
| CN101274024A (zh) | 一种治疗牙疼的药物组合物 | |
| CN102430105A (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN102416121B (zh) | 一种药物组合物在制备治疗胃溃疡的药物中的用途 | |
| CN101912567A (zh) | 治疗慢性心肌炎的中药方剂 | |
| CN102430073B (zh) | 一种治疗消化性溃疡的药物组合物 | |
| CN103212020A (zh) | 一种治疗功能性消化不良的中药组合物 | |
| CN102416120B (zh) | 一种药物组合物在制备治疗糜烂性胃炎的药物中的用途 | |
| CN1616041A (zh) | 一种治疗慢性溃疡性结肠炎的中药组合物 | |
| CN1686500A (zh) | 治疗胸痹的中药制剂 | |
| CN1562232A (zh) | 一种治疗口腔溃疡的药物 | |
| CN102416122B (zh) | 一种药物组合物在制备治疗十二指肠溃疡的药物中的用途 | |
| CN1537559A (zh) | 一种治疗艾滋病的中药 | |
| CN117717594B (zh) | 一种用于治疗腰肌劳损的中药组合物及其制备方法和应用 | |
| CN103599185B (zh) | 一种用于治疗头痛的中药组合物 | |
| CN100348252C (zh) | 一种保肝通便中药制品 | |
| CN1309412C (zh) | 一种治疗艾滋病的药物组合物及其制备方法 | |
| CN100411672C (zh) | 一种治疗银屑病的药物组合物 | |
| CN101224295A (zh) | 一种治疗消化系统肿瘤的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060308 Termination date: 20100521 |